CA1059523A - 3-aminoindazole-1 and 2-carboxylic acid derivatives - Google Patents
3-aminoindazole-1 and 2-carboxylic acid derivativesInfo
- Publication number
- CA1059523A CA1059523A CA240,662A CA240662A CA1059523A CA 1059523 A CA1059523 A CA 1059523A CA 240662 A CA240662 A CA 240662A CA 1059523 A CA1059523 A CA 1059523A
- Authority
- CA
- Canada
- Prior art keywords
- amino
- carboxylic acid
- hydrogen
- lower alkyl
- trifluoromethyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- -1 nitro, amino Chemical group 0.000 claims abstract description 59
- 150000001875 compounds Chemical class 0.000 claims abstract description 46
- 239000001257 hydrogen Substances 0.000 claims abstract description 44
- 229910052739 hydrogen Inorganic materials 0.000 claims abstract description 44
- 125000000217 alkyl group Chemical group 0.000 claims abstract description 37
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 claims abstract description 34
- 125000003545 alkoxy group Chemical group 0.000 claims abstract description 33
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 claims abstract description 26
- 150000003839 salts Chemical class 0.000 claims abstract description 19
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims abstract description 14
- 231100000252 nontoxic Toxicity 0.000 claims abstract description 14
- 230000003000 nontoxic effect Effects 0.000 claims abstract description 14
- 125000003282 alkyl amino group Chemical group 0.000 claims abstract description 11
- YDTDKKULPWTHRV-UHFFFAOYSA-N 1H-indazol-3-amine Chemical class C1=CC=C2C(N)=NNC2=C1 YDTDKKULPWTHRV-UHFFFAOYSA-N 0.000 claims abstract description 9
- 125000004093 cyano group Chemical group *C#N 0.000 claims abstract description 9
- 125000002485 formyl group Chemical group [H]C(*)=O 0.000 claims abstract description 9
- 238000006317 isomerization reaction Methods 0.000 claims abstract description 8
- 125000005236 alkanoylamino group Chemical group 0.000 claims abstract description 6
- CLWMVTQOGTXMIA-UHFFFAOYSA-N ethyl 3-amino-6-chloroindazole-1-carboxylate Chemical compound C1=C(Cl)C=C2N(C(=O)OCC)N=C(N)C2=C1 CLWMVTQOGTXMIA-UHFFFAOYSA-N 0.000 claims abstract description 4
- 239000002253 acid Substances 0.000 claims description 42
- 238000000034 method Methods 0.000 claims description 30
- 230000008569 process Effects 0.000 claims description 26
- 125000001309 chloro group Chemical group Cl* 0.000 claims description 23
- 150000002431 hydrogen Chemical group 0.000 claims description 20
- 125000004494 ethyl ester group Chemical group 0.000 claims description 18
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims description 17
- VALAPLVTFQMOCJ-UHFFFAOYSA-N 3-aminoindazole-1-carboxylic acid Chemical compound C1=CC=C2C(N)=NN(C(O)=O)C2=C1 VALAPLVTFQMOCJ-UHFFFAOYSA-N 0.000 claims description 14
- ZXZTZRVCWTWKCH-UHFFFAOYSA-N 5-(trifluoromethyl)-1h-indazol-3-amine Chemical compound C1=C(C(F)(F)F)C=C2C(N)=NNC2=C1 ZXZTZRVCWTWKCH-UHFFFAOYSA-N 0.000 claims description 14
- 239000000126 substance Substances 0.000 claims description 14
- FFYPMLJYZAEMQB-UHFFFAOYSA-N diethyl pyrocarbonate Chemical compound CCOC(=O)OC(=O)OCC FFYPMLJYZAEMQB-UHFFFAOYSA-N 0.000 claims description 13
- 238000002360 preparation method Methods 0.000 claims description 13
- BPTYMRSBTUERSW-UHFFFAOYSA-N 6-chloro-1h-indazol-3-amine Chemical compound ClC1=CC=C2C(N)=NNC2=C1 BPTYMRSBTUERSW-UHFFFAOYSA-N 0.000 claims description 10
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims description 10
- 238000010438 heat treatment Methods 0.000 claims description 10
- RIFGWPKJUGCATF-UHFFFAOYSA-N ethyl chloroformate Chemical compound CCOC(Cl)=O RIFGWPKJUGCATF-UHFFFAOYSA-N 0.000 claims description 7
- 125000005843 halogen group Chemical group 0.000 claims description 6
- 125000003453 indazolyl group Chemical group N1N=C(C2=C1C=CC=C2)* 0.000 claims description 5
- WUWYYSMJEGBXJL-UHFFFAOYSA-N 6-chloro-n,n-dimethyl-1h-indazol-3-amine Chemical compound ClC1=CC=C2C(N(C)C)=NNC2=C1 WUWYYSMJEGBXJL-UHFFFAOYSA-N 0.000 claims description 4
- 150000001714 carbamic acid halides Chemical class 0.000 claims description 3
- UVAXVHRHEUHJJK-UHFFFAOYSA-N ethyl 3-amino-6-chloroindazole-2-carboxylate Chemical compound C1=C(Cl)C=CC2=C(N)N(C(=O)OCC)N=C21 UVAXVHRHEUHJJK-UHFFFAOYSA-N 0.000 claims description 3
- 239000012948 isocyanate Substances 0.000 claims description 3
- XMJHPCRAQCTCFT-UHFFFAOYSA-N methyl chloroformate Chemical compound COC(Cl)=O XMJHPCRAQCTCFT-UHFFFAOYSA-N 0.000 claims description 3
- ZMPFPQFXUYYHSJ-UHFFFAOYSA-N 6-(trifluoromethyl)-1h-indazol-3-amine Chemical compound FC(F)(F)C1=CC=C2C(N)=NNC2=C1 ZMPFPQFXUYYHSJ-UHFFFAOYSA-N 0.000 claims description 2
- 125000005907 alkyl ester group Chemical group 0.000 claims description 2
- 230000002152 alkylating effect Effects 0.000 claims description 2
- HXVNAFZATKDCQT-UHFFFAOYSA-N ethyl 3-amino-5-(trifluoromethyl)indazole-2-carboxylate Chemical compound C1=CC(C(F)(F)F)=CC2=C(N)N(C(=O)OCC)N=C21 HXVNAFZATKDCQT-UHFFFAOYSA-N 0.000 claims description 2
- FCVFXSHIKIITAJ-UHFFFAOYSA-N methyl 3-amino-5-(trifluoromethyl)indazole-2-carboxylate Chemical compound C1=CC(C(F)(F)F)=CC2=C(N)N(C(=O)OC)N=C21 FCVFXSHIKIITAJ-UHFFFAOYSA-N 0.000 claims description 2
- 125000001664 diethylamino group Chemical group [H]C([H])([H])C([H])([H])N(*)C([H])([H])C([H])([H])[H] 0.000 claims 12
- QJJHWZXKLKDVJO-UHFFFAOYSA-N 3-aminoindazole-2-carboxylic acid Chemical class C1=CC=CC2=C(N)N(C(O)=O)N=C21 QJJHWZXKLKDVJO-UHFFFAOYSA-N 0.000 claims 11
- UGXOEWBGAICBHP-UHFFFAOYSA-N ethyl 3-amino-5-(trifluoromethyl)indazole-1-carboxylate Chemical compound FC(F)(F)C1=CC=C2N(C(=O)OCC)N=C(N)C2=C1 UGXOEWBGAICBHP-UHFFFAOYSA-N 0.000 claims 2
- BPRBZPNDXRAZOL-UHFFFAOYSA-N ethyl 3-amino-6-(trifluoromethyl)indazole-1-carboxylate Chemical compound C1=C(C(F)(F)F)C=C2N(C(=O)OCC)N=C(N)C2=C1 BPRBZPNDXRAZOL-UHFFFAOYSA-N 0.000 claims 2
- RHNHZZJVHSIFSH-UHFFFAOYSA-N methyl 3-amino-5-(trifluoromethyl)indazole-1-carboxylate Chemical compound FC(F)(F)C1=CC=C2N(C(=O)OC)N=C(N)C2=C1 RHNHZZJVHSIFSH-UHFFFAOYSA-N 0.000 claims 2
- GZDFHIJNHHMENY-UHFFFAOYSA-N Dimethyl dicarbonate Chemical compound COC(=O)OC(=O)OC GZDFHIJNHHMENY-UHFFFAOYSA-N 0.000 claims 1
- 230000015572 biosynthetic process Effects 0.000 claims 1
- ZFTFAPZRGNKQPU-UHFFFAOYSA-L carboxylato carbonate Chemical compound [O-]C(=O)OC([O-])=O ZFTFAPZRGNKQPU-UHFFFAOYSA-L 0.000 claims 1
- DIQZIFZMFAPMQB-UHFFFAOYSA-N ethyl 3-amino-6-(trifluoromethyl)indazole-2-carboxylate Chemical compound C1=C(C(F)(F)F)C=CC2=C(N)N(C(=O)OCC)N=C21 DIQZIFZMFAPMQB-UHFFFAOYSA-N 0.000 claims 1
- 230000000202 analgesic effect Effects 0.000 abstract description 7
- 239000002221 antipyretic Substances 0.000 abstract description 4
- 229940125716 antipyretic agent Drugs 0.000 abstract description 2
- BVKZGUZCCUSVTD-UHFFFAOYSA-N carbonic acid Chemical compound OC(O)=O BVKZGUZCCUSVTD-UHFFFAOYSA-N 0.000 abstract description 2
- 125000001475 halogen functional group Chemical group 0.000 abstract 1
- 238000002844 melting Methods 0.000 description 56
- 230000008018 melting Effects 0.000 description 56
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 28
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 22
- LQNUZADURLCDLV-UHFFFAOYSA-N nitrobenzene Chemical compound [O-][N+](=O)C1=CC=CC=C1 LQNUZADURLCDLV-UHFFFAOYSA-N 0.000 description 16
- 239000000203 mixture Substances 0.000 description 15
- 241001465754 Metazoa Species 0.000 description 14
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 12
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 11
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 10
- 239000007795 chemical reaction product Substances 0.000 description 10
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 9
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 9
- 239000000243 solution Substances 0.000 description 9
- SMWDFEZZVXVKRB-UHFFFAOYSA-N Quinoline Chemical compound N1=CC=CC2=CC=CC=C21 SMWDFEZZVXVKRB-UHFFFAOYSA-N 0.000 description 8
- 238000012360 testing method Methods 0.000 description 8
- 241000700159 Rattus Species 0.000 description 7
- 230000001754 anti-pyretic effect Effects 0.000 description 7
- ZFTFAPZRGNKQPU-UHFFFAOYSA-N dicarbonic acid Chemical compound OC(=O)OC(O)=O ZFTFAPZRGNKQPU-UHFFFAOYSA-N 0.000 description 7
- QKIUAMUSENSFQQ-UHFFFAOYSA-N dimethylazanide Chemical compound C[N-]C QKIUAMUSENSFQQ-UHFFFAOYSA-N 0.000 description 7
- 150000004702 methyl esters Chemical class 0.000 description 7
- 239000000843 powder Substances 0.000 description 7
- 239000002904 solvent Substances 0.000 description 7
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 6
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 6
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 6
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 6
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 6
- 239000002585 base Substances 0.000 description 6
- 150000001732 carboxylic acid derivatives Chemical class 0.000 description 6
- 238000006243 chemical reaction Methods 0.000 description 6
- 239000003085 diluting agent Substances 0.000 description 6
- 150000002148 esters Chemical class 0.000 description 6
- 210000002683 foot Anatomy 0.000 description 6
- RFFLAFLAYFXFSW-UHFFFAOYSA-N 1,2-dichlorobenzene Chemical compound ClC1=CC=CC=C1Cl RFFLAFLAYFXFSW-UHFFFAOYSA-N 0.000 description 5
- BAXOFTOLAUCFNW-UHFFFAOYSA-N 1H-indazole Chemical compound C1=CC=C2C=NNC2=C1 BAXOFTOLAUCFNW-UHFFFAOYSA-N 0.000 description 5
- DNSISZSEWVHGLH-UHFFFAOYSA-N butanamide Chemical compound CCCC(N)=O DNSISZSEWVHGLH-UHFFFAOYSA-N 0.000 description 5
- 239000003981 vehicle Substances 0.000 description 5
- NWZSZGALRFJKBT-KNIFDHDWSA-N (2s)-2,6-diaminohexanoic acid;(2s)-2-hydroxybutanedioic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O.NCCCC[C@H](N)C(O)=O NWZSZGALRFJKBT-KNIFDHDWSA-N 0.000 description 4
- HZAXFHJVJLSVMW-UHFFFAOYSA-N 2-Aminoethan-1-ol Chemical compound NCCO HZAXFHJVJLSVMW-UHFFFAOYSA-N 0.000 description 4
- BSKHPKMHTQYZBB-UHFFFAOYSA-N 2-methylpyridine Chemical class CC1=CC=CC=N1 BSKHPKMHTQYZBB-UHFFFAOYSA-N 0.000 description 4
- NORAFCGXPPSBTR-UHFFFAOYSA-N 3-amino-6-chloroindazole-1-carboxylic acid Chemical compound ClC1=CC=C2C(N)=NN(C(O)=O)C2=C1 NORAFCGXPPSBTR-UHFFFAOYSA-N 0.000 description 4
- WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 description 4
- 230000009471 action Effects 0.000 description 4
- 230000003110 anti-inflammatory effect Effects 0.000 description 4
- 230000036760 body temperature Effects 0.000 description 4
- 238000009835 boiling Methods 0.000 description 4
- 238000001816 cooling Methods 0.000 description 4
- 125000004177 diethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 4
- 239000002552 dosage form Substances 0.000 description 4
- 238000001704 evaporation Methods 0.000 description 4
- IKDUDTNKRLTJSI-UHFFFAOYSA-N hydrazine monohydrate Substances O.NN IKDUDTNKRLTJSI-UHFFFAOYSA-N 0.000 description 4
- AWJUIBRHMBBTKR-UHFFFAOYSA-N isoquinoline Chemical compound C1=NC=CC2=CC=CC=C21 AWJUIBRHMBBTKR-UHFFFAOYSA-N 0.000 description 4
- 239000000047 product Substances 0.000 description 4
- 230000035484 reaction time Effects 0.000 description 4
- DCKVNWZUADLDEH-UHFFFAOYSA-N sec-butyl acetate Chemical compound CCC(C)OC(C)=O DCKVNWZUADLDEH-UHFFFAOYSA-N 0.000 description 4
- 239000007858 starting material Substances 0.000 description 4
- 239000000725 suspension Substances 0.000 description 4
- 239000006188 syrup Substances 0.000 description 4
- 235000020357 syrup Nutrition 0.000 description 4
- VZGDMQKNWNREIO-UHFFFAOYSA-N tetrachloromethane Chemical compound ClC(Cl)(Cl)Cl VZGDMQKNWNREIO-UHFFFAOYSA-N 0.000 description 4
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 3
- OISVCGZHLKNMSJ-UHFFFAOYSA-N 2,6-dimethylpyridine Chemical class CC1=CC=CC(C)=N1 OISVCGZHLKNMSJ-UHFFFAOYSA-N 0.000 description 3
- RLQZIECDMISZHS-UHFFFAOYSA-N 2-phenylcyclohexa-2,5-diene-1,4-dione Chemical compound O=C1C=CC(=O)C(C=2C=CC=CC=2)=C1 RLQZIECDMISZHS-UHFFFAOYSA-N 0.000 description 3
- CYYYIVVNEIXBKM-UHFFFAOYSA-N 3-amino-1h-indazole-5-carbonitrile Chemical compound C1=C(C#N)C=C2C(N)=NNC2=C1 CYYYIVVNEIXBKM-UHFFFAOYSA-N 0.000 description 3
- BWVJNNOSBGNBIN-UHFFFAOYSA-N 3-amino-4,6-dimethyl-1h-indazole-5-carbonitrile Chemical compound CC1=C(C#N)C(C)=CC2=C1C(N)=NN2 BWVJNNOSBGNBIN-UHFFFAOYSA-N 0.000 description 3
- BZJVBMXZYYDTBN-UHFFFAOYSA-N 3-amino-6-chloro-n,n-dimethylindazole-2-carboxamide Chemical compound C1=C(Cl)C=CC2=C(N)N(C(=O)N(C)C)N=C21 BZJVBMXZYYDTBN-UHFFFAOYSA-N 0.000 description 3
- QPLXQNVPEHUPTR-UHFFFAOYSA-N 4-chloro-1H-indazol-3-amine Chemical compound C1=CC(Cl)=C2C(N)=NNC2=C1 QPLXQNVPEHUPTR-UHFFFAOYSA-N 0.000 description 3
- YNUURDFRONKMMP-UHFFFAOYSA-N 7-nitro-5-(trifluoromethyl)-1h-indazol-3-amine Chemical compound C1=C(C(F)(F)F)C=C2C(N)=NNC2=C1[N+]([O-])=O YNUURDFRONKMMP-UHFFFAOYSA-N 0.000 description 3
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 3
- YIIMEMSDCNDGTB-UHFFFAOYSA-N Dimethylcarbamoyl chloride Chemical compound CN(C)C(Cl)=O YIIMEMSDCNDGTB-UHFFFAOYSA-N 0.000 description 3
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 3
- QUSNBJAOOMFDIB-UHFFFAOYSA-N Ethylamine Chemical compound CCN QUSNBJAOOMFDIB-UHFFFAOYSA-N 0.000 description 3
- CTQNGGLPUBDAKN-UHFFFAOYSA-N O-Xylene Chemical compound CC1=CC=CC=C1C CTQNGGLPUBDAKN-UHFFFAOYSA-N 0.000 description 3
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 3
- 229920002472 Starch Polymers 0.000 description 3
- 230000037396 body weight Effects 0.000 description 3
- 125000001246 bromo group Chemical group Br* 0.000 description 3
- 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 3
- 239000002775 capsule Substances 0.000 description 3
- 125000004432 carbon atom Chemical group C* 0.000 description 3
- 235000010418 carrageenan Nutrition 0.000 description 3
- 229920001525 carrageenan Polymers 0.000 description 3
- 125000000118 dimethyl group Chemical group [H]C([H])([H])* 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 150000002170 ethers Chemical class 0.000 description 3
- PJFXDPZWCVXNQZ-UHFFFAOYSA-N ethyl 3-oxo-1,2-dihydropyrazole-4-carboxylate Chemical group CCOC(=O)C1=CNNC1=O PJFXDPZWCVXNQZ-UHFFFAOYSA-N 0.000 description 3
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 3
- 230000008020 evaporation Effects 0.000 description 3
- 125000000623 heterocyclic group Chemical group 0.000 description 3
- 150000002430 hydrocarbons Chemical group 0.000 description 3
- 239000007924 injection Substances 0.000 description 3
- 238000002347 injection Methods 0.000 description 3
- 239000000463 material Substances 0.000 description 3
- 238000002156 mixing Methods 0.000 description 3
- 125000004108 n-butyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 3
- 239000003960 organic solvent Substances 0.000 description 3
- 230000008707 rearrangement Effects 0.000 description 3
- 239000008107 starch Substances 0.000 description 3
- 235000019698 starch Nutrition 0.000 description 3
- 238000003756 stirring Methods 0.000 description 3
- 239000013589 supplement Substances 0.000 description 3
- CXWXQJXEFPUFDZ-UHFFFAOYSA-N tetralin Chemical compound C1=CC=C2CCCCC2=C1 CXWXQJXEFPUFDZ-UHFFFAOYSA-N 0.000 description 3
- 239000008096 xylene Substances 0.000 description 3
- ZEDPQIJYJCPIRM-UHFFFAOYSA-N 2,3-dimethylbenzonitrile Chemical compound CC1=CC=CC(C#N)=C1C ZEDPQIJYJCPIRM-UHFFFAOYSA-N 0.000 description 2
- BWZVCCNYKMEVEX-UHFFFAOYSA-N 2,4,6-Trimethylpyridine Chemical compound CC1=CC(C)=NC(C)=C1 BWZVCCNYKMEVEX-UHFFFAOYSA-N 0.000 description 2
- QSACPWSIIRFHHR-UHFFFAOYSA-N 2,6-dimethylbenzonitrile Chemical compound CC1=CC=CC(C)=C1C#N QSACPWSIIRFHHR-UHFFFAOYSA-N 0.000 description 2
- VGUWZCUCNQXGBU-UHFFFAOYSA-N 3-[(4-methylpiperazin-1-yl)methyl]-5-nitro-1h-indole Chemical compound C1CN(C)CCN1CC1=CNC2=CC=C([N+]([O-])=O)C=C12 VGUWZCUCNQXGBU-UHFFFAOYSA-N 0.000 description 2
- GCTUMEMEEJCXDV-UHFFFAOYSA-N 3-amino-5-chloroindazole-1-carboxylic acid Chemical compound C1=C(Cl)C=C2C(N)=NN(C(O)=O)C2=C1 GCTUMEMEEJCXDV-UHFFFAOYSA-N 0.000 description 2
- WQSZTNMTDPQSTB-UHFFFAOYSA-N 3-amino-6-chloroindazole-2-carboxylic acid Chemical compound C1=C(Cl)C=CC2=C(N)N(C(O)=O)N=C21 WQSZTNMTDPQSTB-UHFFFAOYSA-N 0.000 description 2
- ITQTTZVARXURQS-UHFFFAOYSA-N 3-methylpyridine Chemical compound CC1=CC=CN=C1 ITQTTZVARXURQS-UHFFFAOYSA-N 0.000 description 2
- HVSPPLIBICHWSB-UHFFFAOYSA-N 4-(trifluoromethyl)-1h-indazol-3-amine Chemical compound C1=CC(C(F)(F)F)=C2C(N)=NNC2=C1 HVSPPLIBICHWSB-UHFFFAOYSA-N 0.000 description 2
- FKNQCJSGGFJEIZ-UHFFFAOYSA-N 4-methylpyridine Chemical compound CC1=CC=NC=C1 FKNQCJSGGFJEIZ-UHFFFAOYSA-N 0.000 description 2
- ZRBIRODWUCDBLY-UHFFFAOYSA-N 5-(trifluoromethyl)-1h-indazole-3,7-diamine Chemical compound C1=C(C(F)(F)F)C=C2C(N)=NNC2=C1N ZRBIRODWUCDBLY-UHFFFAOYSA-N 0.000 description 2
- JLLYLQLDYORLBB-UHFFFAOYSA-N 5-bromo-n-methylthiophene-2-sulfonamide Chemical compound CNS(=O)(=O)C1=CC=C(Br)S1 JLLYLQLDYORLBB-UHFFFAOYSA-N 0.000 description 2
- QCSQTZOPSNFNNX-UHFFFAOYSA-N 5-chloro-1h-indazol-3-amine Chemical compound C1=C(Cl)C=C2C(N)=NNC2=C1 QCSQTZOPSNFNNX-UHFFFAOYSA-N 0.000 description 2
- SWZRTDLKPZAFDT-UHFFFAOYSA-N 5-nitro-1h-indazol-3-amine Chemical compound C1=C([N+]([O-])=O)C=C2C(N)=NNC2=C1 SWZRTDLKPZAFDT-UHFFFAOYSA-N 0.000 description 2
- VUZQHUVRBPILAX-UHFFFAOYSA-N 6-chloro-1h-indazole Chemical compound ClC1=CC=C2C=NNC2=C1 VUZQHUVRBPILAX-UHFFFAOYSA-N 0.000 description 2
- RLNKCXFTRPDGAP-UHFFFAOYSA-N 7-(trifluoromethyl)-1h-indazol-3-amine Chemical compound C1=CC=C2C(N)=NNC2=C1C(F)(F)F RLNKCXFTRPDGAP-UHFFFAOYSA-N 0.000 description 2
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 2
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 2
- ROSDSFDQCJNGOL-UHFFFAOYSA-N Dimethylamine Chemical compound CNC ROSDSFDQCJNGOL-UHFFFAOYSA-N 0.000 description 2
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 2
- 238000005684 Liebig rearrangement reaction Methods 0.000 description 2
- YNAVUWVOSKDBBP-UHFFFAOYSA-N Morpholine Chemical compound C1COCCN1 YNAVUWVOSKDBBP-UHFFFAOYSA-N 0.000 description 2
- FXHOOIRPVKKKFG-UHFFFAOYSA-N N,N-Dimethylacetamide Chemical compound CN(C)C(C)=O FXHOOIRPVKKKFG-UHFFFAOYSA-N 0.000 description 2
- JLTDJTHDQAWBAV-UHFFFAOYSA-N N,N-dimethylaniline Chemical compound CN(C)C1=CC=CC=C1 JLTDJTHDQAWBAV-UHFFFAOYSA-N 0.000 description 2
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 2
- 206010030113 Oedema Diseases 0.000 description 2
- NQRYJNQNLNOLGT-UHFFFAOYSA-N Piperidine Chemical compound C1CCNCC1 NQRYJNQNLNOLGT-UHFFFAOYSA-N 0.000 description 2
- 239000007868 Raney catalyst Substances 0.000 description 2
- NPXOKRUENSOPAO-UHFFFAOYSA-N Raney nickel Chemical compound [Al].[Ni] NPXOKRUENSOPAO-UHFFFAOYSA-N 0.000 description 2
- 229910000564 Raney nickel Inorganic materials 0.000 description 2
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 2
- 235000014680 Saccharomyces cerevisiae Nutrition 0.000 description 2
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 2
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 2
- 229930006000 Sucrose Natural products 0.000 description 2
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 2
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 2
- 239000011149 active material Substances 0.000 description 2
- 230000007059 acute toxicity Effects 0.000 description 2
- 231100000403 acute toxicity Toxicity 0.000 description 2
- 229910052784 alkaline earth metal Inorganic materials 0.000 description 2
- 150000001412 amines Chemical class 0.000 description 2
- RDOXTESZEPMUJZ-UHFFFAOYSA-N anisole Chemical compound COC1=CC=CC=C1 RDOXTESZEPMUJZ-UHFFFAOYSA-N 0.000 description 2
- WGQKYBSKWIADBV-UHFFFAOYSA-N benzylamine Chemical compound NCC1=CC=CC=C1 WGQKYBSKWIADBV-UHFFFAOYSA-N 0.000 description 2
- 239000011230 binding agent Substances 0.000 description 2
- HUBISKJGWFPBSL-UHFFFAOYSA-N butyl 3-amino-6-chloroindazole-2-carboxylate Chemical compound C1=C(Cl)C=CC2=C(N)N(C(=O)OCCCC)N=C21 HUBISKJGWFPBSL-UHFFFAOYSA-N 0.000 description 2
- 238000009903 catalytic hydrogenation reaction Methods 0.000 description 2
- MVPPADPHJFYWMZ-UHFFFAOYSA-N chlorobenzene Chemical compound ClC1=CC=CC=C1 MVPPADPHJFYWMZ-UHFFFAOYSA-N 0.000 description 2
- 238000000576 coating method Methods 0.000 description 2
- 239000003937 drug carrier Substances 0.000 description 2
- SQNFRGVSWXVJTJ-UHFFFAOYSA-N ethyl 3-aminoindazole-2-carboxylate Chemical compound C1=CC=CC2=C(N)N(C(=O)OCC)N=C21 SQNFRGVSWXVJTJ-UHFFFAOYSA-N 0.000 description 2
- MIKBUCCDOOVIMQ-UHFFFAOYSA-N ethyl 6-chloro-3-(dimethylamino)indazole-1-carboxylate Chemical compound C1=C(Cl)C=C2N(C(=O)OCC)N=C(N(C)C)C2=C1 MIKBUCCDOOVIMQ-UHFFFAOYSA-N 0.000 description 2
- WUDNUHPRLBTKOJ-UHFFFAOYSA-N ethyl isocyanate Chemical compound CCN=C=O WUDNUHPRLBTKOJ-UHFFFAOYSA-N 0.000 description 2
- 238000011049 filling Methods 0.000 description 2
- 238000001914 filtration Methods 0.000 description 2
- 239000012530 fluid Substances 0.000 description 2
- 238000003682 fluorination reaction Methods 0.000 description 2
- 239000008187 granular material Substances 0.000 description 2
- 150000005826 halohydrocarbons Chemical class 0.000 description 2
- 230000005764 inhibitory process Effects 0.000 description 2
- 150000007529 inorganic bases Chemical class 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 239000000314 lubricant Substances 0.000 description 2
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 description 2
- 238000005259 measurement Methods 0.000 description 2
- BDAGIHXWWSANSR-UHFFFAOYSA-N methanoic acid Natural products OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 description 2
- 125000001160 methoxycarbonyl group Chemical group [H]C([H])([H])OC(*)=O 0.000 description 2
- RCVKOTDDPFBOOM-UHFFFAOYSA-N methyl 3-amino-6-chloroindazole-1-carboxylate Chemical compound C1=C(Cl)C=C2N(C(=O)OC)N=C(N)C2=C1 RCVKOTDDPFBOOM-UHFFFAOYSA-N 0.000 description 2
- HAMGRBXTJNITHG-UHFFFAOYSA-N methyl isocyanate Chemical compound CN=C=O HAMGRBXTJNITHG-UHFFFAOYSA-N 0.000 description 2
- 150000002825 nitriles Chemical class 0.000 description 2
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 2
- 150000007530 organic bases Chemical class 0.000 description 2
- 238000007911 parenteral administration Methods 0.000 description 2
- 239000008194 pharmaceutical composition Substances 0.000 description 2
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 description 2
- NJSJBTVAKUBCKG-UHFFFAOYSA-N propylazanide Chemical compound CCC[NH-] NJSJBTVAKUBCKG-UHFFFAOYSA-N 0.000 description 2
- ODZPKZBBUMBTMG-UHFFFAOYSA-N sodium amide Chemical compound [NH2-].[Na+] ODZPKZBBUMBTMG-UHFFFAOYSA-N 0.000 description 2
- 125000001424 substituent group Chemical group 0.000 description 2
- 239000005720 sucrose Substances 0.000 description 2
- 239000000454 talc Substances 0.000 description 2
- 229910052623 talc Inorganic materials 0.000 description 2
- 235000012222 talc Nutrition 0.000 description 2
- 230000001225 therapeutic effect Effects 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- LDDMACCNBZAMSG-BDVNFPICSA-N (2r,3r,4s,5r)-3,4,5,6-tetrahydroxy-2-(methylamino)hexanal Chemical compound CN[C@@H](C=O)[C@@H](O)[C@H](O)[C@H](O)CO LDDMACCNBZAMSG-BDVNFPICSA-N 0.000 description 1
- DURPTKYDGMDSBL-UHFFFAOYSA-N 1-butoxybutane Chemical compound CCCCOCCCC DURPTKYDGMDSBL-UHFFFAOYSA-N 0.000 description 1
- RRQYJINTUHWNHW-UHFFFAOYSA-N 1-ethoxy-2-(2-ethoxyethoxy)ethane Chemical compound CCOCCOCCOCC RRQYJINTUHWNHW-UHFFFAOYSA-N 0.000 description 1
- OQURWGJAWSLGQG-UHFFFAOYSA-N 1-isocyanatopropane Chemical compound CCCN=C=O OQURWGJAWSLGQG-UHFFFAOYSA-N 0.000 description 1
- YEMKWBWXEDYERK-UHFFFAOYSA-N 1h-indazole-3,5,7-triamine Chemical compound C1=C(N)C=C2C(N)=NNC2=C1N YEMKWBWXEDYERK-UHFFFAOYSA-N 0.000 description 1
- GHFKCBWRZWDFKB-UHFFFAOYSA-N 1h-indazole-3,5-diamine Chemical compound C1=C(N)C=C2C(N)=NNC2=C1 GHFKCBWRZWDFKB-UHFFFAOYSA-N 0.000 description 1
- YQTCQNIPQMJNTI-UHFFFAOYSA-N 2,2-dimethylpropan-1-one Chemical group CC(C)(C)[C]=O YQTCQNIPQMJNTI-UHFFFAOYSA-N 0.000 description 1
- RIZUCYSQUWMQLX-UHFFFAOYSA-N 2,3-dimethylbenzoic acid Chemical compound CC1=CC=CC(C(O)=O)=C1C RIZUCYSQUWMQLX-UHFFFAOYSA-N 0.000 description 1
- KZTWONRVIPPDKH-UHFFFAOYSA-N 2-(piperidin-1-yl)ethanol Chemical compound OCCN1CCCCC1 KZTWONRVIPPDKH-UHFFFAOYSA-N 0.000 description 1
- MSWZFWKMSRAUBD-IVMDWMLBSA-N 2-amino-2-deoxy-D-glucopyranose Chemical compound N[C@H]1C(O)O[C@H](CO)[C@@H](O)[C@@H]1O MSWZFWKMSRAUBD-IVMDWMLBSA-N 0.000 description 1
- GANPUEIPQFDYQA-UHFFFAOYSA-N 2-chloro-3-(trifluoromethyl)benzonitrile Chemical compound FC(F)(F)C1=CC=CC(C#N)=C1Cl GANPUEIPQFDYQA-UHFFFAOYSA-N 0.000 description 1
- BFSVOASYOCHEOV-UHFFFAOYSA-N 2-diethylaminoethanol Chemical compound CCN(CC)CCO BFSVOASYOCHEOV-UHFFFAOYSA-N 0.000 description 1
- MGOLNIXAPIAKFM-UHFFFAOYSA-N 2-isocyanato-2-methylpropane Chemical compound CC(C)(C)N=C=O MGOLNIXAPIAKFM-UHFFFAOYSA-N 0.000 description 1
- GSLTVFIVJMCNBH-UHFFFAOYSA-N 2-isocyanatopropane Chemical compound CC(C)N=C=O GSLTVFIVJMCNBH-UHFFFAOYSA-N 0.000 description 1
- SRGZHEAAWCZVNP-UHFFFAOYSA-N 2-methoxy-3-nitro-5-(trifluoromethyl)benzonitrile Chemical compound COC1=C(C#N)C=C(C(F)(F)F)C=C1[N+]([O-])=O SRGZHEAAWCZVNP-UHFFFAOYSA-N 0.000 description 1
- CRWNQZTZTZWPOF-UHFFFAOYSA-N 2-methyl-4-phenylpyridine Chemical compound C1=NC(C)=CC(C=2C=CC=CC=2)=C1 CRWNQZTZTZWPOF-UHFFFAOYSA-N 0.000 description 1
- PJVACBOIQLBALV-UHFFFAOYSA-N 3-(trifluoromethyl)-2h-indazole Chemical compound C1=CC=CC2=C(C(F)(F)F)NN=C21 PJVACBOIQLBALV-UHFFFAOYSA-N 0.000 description 1
- MJSBZSAMJGPJGK-UHFFFAOYSA-N 3-amino-5,6-dimethoxyindazole-1-carboxylic acid Chemical compound C1=C(OC)C(OC)=CC2=C1N(C(O)=O)N=C2N MJSBZSAMJGPJGK-UHFFFAOYSA-N 0.000 description 1
- PLWYOWQIDHNBDH-UHFFFAOYSA-N 3-amino-5-(trifluoromethyl)indazole-1-carboxylic acid Chemical compound C1=C(C(F)(F)F)C=C2C(N)=NN(C(O)=O)C2=C1 PLWYOWQIDHNBDH-UHFFFAOYSA-N 0.000 description 1
- UNDWUMOWSIHOMF-UHFFFAOYSA-N 3-amino-5-(trifluoromethyl)indazole-2-carboxylic acid Chemical compound C1=CC(C(F)(F)F)=CC2=C(N)N(C(O)=O)N=C21 UNDWUMOWSIHOMF-UHFFFAOYSA-N 0.000 description 1
- YNQKJTOKMSMGHV-UHFFFAOYSA-N 3-amino-5-bromoindazole-1-carboxylic acid Chemical compound C1=C(Br)C=C2C(N)=NN(C(O)=O)C2=C1 YNQKJTOKMSMGHV-UHFFFAOYSA-N 0.000 description 1
- DUEVLXWPERGXQB-UHFFFAOYSA-N 3-amino-6-chloro-n-methylindazole-1-carboxamide Chemical compound C1=C(Cl)C=C2N(C(=O)NC)N=C(N)C2=C1 DUEVLXWPERGXQB-UHFFFAOYSA-N 0.000 description 1
- WVVVMFDTENGKDM-UHFFFAOYSA-N 3-amino-7-nitro-1h-indazole-5-carbonitrile Chemical compound C1=C(C#N)C=C2C(N)=NNC2=C1[N+]([O-])=O WVVVMFDTENGKDM-UHFFFAOYSA-N 0.000 description 1
- PLGYOJBSEDOTML-UHFFFAOYSA-N 3-amino-n,n-dimethylindazole-2-carboxamide Chemical compound C1=CC=CC2=C(N)N(C(=O)N(C)C)N=C21 PLGYOJBSEDOTML-UHFFFAOYSA-N 0.000 description 1
- QPHAGNNWDZSKJH-UHFFFAOYSA-N 3-chloro-2h-indazole Chemical compound C1=CC=CC2=C(Cl)NN=C21 QPHAGNNWDZSKJH-UHFFFAOYSA-N 0.000 description 1
- HBQPUOQPZPUNEJ-UHFFFAOYSA-N 3-ethyl-2h-indazole Chemical compound C1=CC=C2C(CC)=NNC2=C1 HBQPUOQPZPUNEJ-UHFFFAOYSA-N 0.000 description 1
- KARXTMOFQRNVKH-UHFFFAOYSA-N 3-n-methyl-1h-indazole-3,5-diamine Chemical compound C1=C(N)C=C2C(NC)=NNC2=C1 KARXTMOFQRNVKH-UHFFFAOYSA-N 0.000 description 1
- LBUPLFJQXQEYDT-UHFFFAOYSA-N 4,7-dichloro-1h-indazol-3-amine Chemical compound C1=CC(Cl)=C2C(N)=NNC2=C1Cl LBUPLFJQXQEYDT-UHFFFAOYSA-N 0.000 description 1
- SAALZDNQETVVII-UHFFFAOYSA-N 4,7-dimethyl-1h-indazol-3-amine Chemical compound CC1=CC=C(C)C2=C1NN=C2N SAALZDNQETVVII-UHFFFAOYSA-N 0.000 description 1
- OSWFIVFLDKOXQC-UHFFFAOYSA-N 4-(3-methoxyphenyl)aniline Chemical compound COC1=CC=CC(C=2C=CC(N)=CC=2)=C1 OSWFIVFLDKOXQC-UHFFFAOYSA-N 0.000 description 1
- KALFKWQLCWAXJO-WCFLWFBJSA-N 4-[[(1r,7s,7as)-7-hydroxy-1-(trifluoromethyl)-5,6,7,7a-tetrahydro-1h-pyrrolo[1,2-c][1,3]oxazol-3-ylidene]amino]-2-chloro-3-methylbenzonitrile Chemical compound CC1=C(Cl)C(C#N)=CC=C1N=C1N2CC[C@H](O)[C@H]2[C@H](C(F)(F)F)O1 KALFKWQLCWAXJO-WCFLWFBJSA-N 0.000 description 1
- APLYBKHRTXFIBT-UHFFFAOYSA-N 4-chlorobenzene-1,3-dicarboxylic acid Chemical compound OC(=O)C1=CC=C(Cl)C(C(O)=O)=C1 APLYBKHRTXFIBT-UHFFFAOYSA-N 0.000 description 1
- KXPCCBPXQYNNRI-UHFFFAOYSA-N 4-methyl-1h-indazol-3-amine Chemical compound CC1=CC=CC2=C1C(N)=NN2 KXPCCBPXQYNNRI-UHFFFAOYSA-N 0.000 description 1
- XAFOVWFPQUWJPZ-UHFFFAOYSA-N 5,6-diethyl-1h-indazol-3-amine Chemical compound C1=C(CC)C(CC)=CC2=C1C(N)=NN2 XAFOVWFPQUWJPZ-UHFFFAOYSA-N 0.000 description 1
- CHIKJKNEGGLWAU-UHFFFAOYSA-N 5,7-dinitro-1h-indazol-3-amine Chemical compound C1=C([N+]([O-])=O)C=C2C(N)=NNC2=C1[N+]([O-])=O CHIKJKNEGGLWAU-UHFFFAOYSA-N 0.000 description 1
- OMPYFDJVSAMSMA-UHFFFAOYSA-N 5-bromo-1h-indazol-3-amine Chemical compound C1=C(Br)C=C2C(N)=NNC2=C1 OMPYFDJVSAMSMA-UHFFFAOYSA-N 0.000 description 1
- ILPPLUHSTVFJEL-UHFFFAOYSA-N 5-bromo-4-ethyl-1h-indazol-3-amine Chemical compound CCC1=C(Br)C=CC2=C1C(N)=NN2 ILPPLUHSTVFJEL-UHFFFAOYSA-N 0.000 description 1
- CVICEEPAFUYBJG-UHFFFAOYSA-N 5-chloro-2,2-difluoro-1,3-benzodioxole Chemical group C1=C(Cl)C=C2OC(F)(F)OC2=C1 CVICEEPAFUYBJG-UHFFFAOYSA-N 0.000 description 1
- YHMZEHSVPWGDDU-UHFFFAOYSA-N 5-ethoxy-1h-indazol-3-amine Chemical compound CCOC1=CC=C2NN=C(N)C2=C1 YHMZEHSVPWGDDU-UHFFFAOYSA-N 0.000 description 1
- XCFCLXZHHWTVSS-UHFFFAOYSA-N 5-ethyl-6-propan-2-yl-1h-indazol-3-amine Chemical compound C1=C(C(C)C)C(CC)=CC2=C1NN=C2N XCFCLXZHHWTVSS-UHFFFAOYSA-N 0.000 description 1
- FHUOBMHIPDHZDU-UHFFFAOYSA-N 5-methoxy-6-(trifluoromethyl)-1h-indazol-3-amine Chemical compound C1=C(C(F)(F)F)C(OC)=CC2=C1NN=C2N FHUOBMHIPDHZDU-UHFFFAOYSA-N 0.000 description 1
- BDAMCVAGIGMIFW-UHFFFAOYSA-N 5-methyl-1H-indazole-3,4-diamine Chemical compound NC1=NNC2=CC=C(C(=C12)N)C BDAMCVAGIGMIFW-UHFFFAOYSA-N 0.000 description 1
- JXLRHJBXHHQPMN-UHFFFAOYSA-N 5-n,5-n-dimethyl-1h-indazole-3,5-diamine Chemical compound CN(C)C1=CC=C2NN=C(N)C2=C1 JXLRHJBXHHQPMN-UHFFFAOYSA-N 0.000 description 1
- UVUPPLXBIXJRKD-UHFFFAOYSA-N 5-nitro-2h-indazole-3-carbaldehyde Chemical compound C1=C([N+](=O)[O-])C=CC2=NNC(C=O)=C21 UVUPPLXBIXJRKD-UHFFFAOYSA-N 0.000 description 1
- XVMSFILGAMDHEY-UHFFFAOYSA-N 6-(4-aminophenyl)sulfonylpyridin-3-amine Chemical compound C1=CC(N)=CC=C1S(=O)(=O)C1=CC=C(N)C=N1 XVMSFILGAMDHEY-UHFFFAOYSA-N 0.000 description 1
- BWHYEMMKOZBXKJ-UHFFFAOYSA-N 6-butyl-1h-indazol-3-amine Chemical compound CCCCC1=CC=C2C(N)=NNC2=C1 BWHYEMMKOZBXKJ-UHFFFAOYSA-N 0.000 description 1
- KKEAEAJOEOGMKK-UHFFFAOYSA-N 6-chloro-4-ethoxy-1h-indazol-3-amine Chemical compound CCOC1=CC(Cl)=CC2=C1C(N)=NN2 KKEAEAJOEOGMKK-UHFFFAOYSA-N 0.000 description 1
- PVBSARMEIPMJOV-UHFFFAOYSA-N 6-chloro-4-methyl-1h-indazol-3-amine Chemical compound CC1=CC(Cl)=CC2=C1C(N)=NN2 PVBSARMEIPMJOV-UHFFFAOYSA-N 0.000 description 1
- AQPXXORTQAVBIK-UHFFFAOYSA-N 6-ethoxy-n,n-dimethyl-1h-indazol-3-amine Chemical compound CCOC1=CC=C2C(N(C)C)=NNC2=C1 AQPXXORTQAVBIK-UHFFFAOYSA-N 0.000 description 1
- JKOGFRGFWFEFNT-UHFFFAOYSA-N 6-fluoro-1h-indazol-3-amine Chemical compound FC1=CC=C2C(N)=NNC2=C1 JKOGFRGFWFEFNT-UHFFFAOYSA-N 0.000 description 1
- HNOSKPXFWPKCPP-UHFFFAOYSA-N 6-methoxy-1h-indazol-3-amine Chemical compound COC1=CC=C2C(N)=NNC2=C1 HNOSKPXFWPKCPP-UHFFFAOYSA-N 0.000 description 1
- LOXFRCAHUDJGFF-UHFFFAOYSA-N 7-n-butyl-5-(trifluoromethyl)-1h-indazole-3,7-diamine Chemical compound CCCCNC1=CC(C(F)(F)F)=CC2=C1NN=C2N LOXFRCAHUDJGFF-UHFFFAOYSA-N 0.000 description 1
- BCJIDCIVPYISKG-UHFFFAOYSA-N 7-nitro-1h-indazole-3,5-diamine Chemical compound C1=C(N)C=C2C(N)=NNC2=C1[N+]([O-])=O BCJIDCIVPYISKG-UHFFFAOYSA-N 0.000 description 1
- 239000005995 Aluminium silicate Substances 0.000 description 1
- 241001535291 Analges Species 0.000 description 1
- CPELXLSAUQHCOX-UHFFFAOYSA-M Bromide Chemical compound [Br-] CPELXLSAUQHCOX-UHFFFAOYSA-M 0.000 description 1
- QXKAIJAYHKCRRA-JJYYJPOSSA-N D-arabinonic acid Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)C(O)=O QXKAIJAYHKCRRA-JJYYJPOSSA-N 0.000 description 1
- 235000019739 Dicalciumphosphate Nutrition 0.000 description 1
- 101150049580 Esam gene Proteins 0.000 description 1
- PIICEJLVQHRZGT-UHFFFAOYSA-N Ethylenediamine Chemical compound NCCN PIICEJLVQHRZGT-UHFFFAOYSA-N 0.000 description 1
- 241000490229 Eucephalus Species 0.000 description 1
- 241000237858 Gastropoda Species 0.000 description 1
- 108010010803 Gelatin Proteins 0.000 description 1
- 238000004566 IR spectroscopy Methods 0.000 description 1
- 229920006063 Lamide® Polymers 0.000 description 1
- 240000007472 Leucaena leucocephala Species 0.000 description 1
- 235000010643 Leucaena leucocephala Nutrition 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- NTIZESTWPVYFNL-UHFFFAOYSA-N Methyl isobutyl ketone Chemical compound CC(C)CC(C)=O NTIZESTWPVYFNL-UHFFFAOYSA-N 0.000 description 1
- UIHCLUNTQKBZGK-UHFFFAOYSA-N Methyl isobutyl ketone Natural products CCC(C)C(C)=O UIHCLUNTQKBZGK-UHFFFAOYSA-N 0.000 description 1
- 229920000715 Mucilage Polymers 0.000 description 1
- BMYLHMOCQDLNKR-UHFFFAOYSA-N N,N-dimethylindazole-1-carboxamide Chemical compound CN(C(=O)N1N=CC2=CC=CC=C12)C BMYLHMOCQDLNKR-UHFFFAOYSA-N 0.000 description 1
- QOSMNYMQXIVWKY-UHFFFAOYSA-N Propyl levulinate Chemical compound CCCOC(=O)CCC(C)=O QOSMNYMQXIVWKY-UHFFFAOYSA-N 0.000 description 1
- 208000036366 Sensation of pressure Diseases 0.000 description 1
- 229920001800 Shellac Polymers 0.000 description 1
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 1
- 235000021355 Stearic acid Nutrition 0.000 description 1
- LSNNMFCWUKXFEE-UHFFFAOYSA-N Sulfurous acid Chemical compound OS(O)=O LSNNMFCWUKXFEE-UHFFFAOYSA-N 0.000 description 1
- GSEJCLTVZPLZKY-UHFFFAOYSA-N Triethanolamine Chemical compound OCCN(CCO)CCO GSEJCLTVZPLZKY-UHFFFAOYSA-N 0.000 description 1
- 240000004543 Vicia ervilia Species 0.000 description 1
- 210000003489 abdominal muscle Anatomy 0.000 description 1
- 125000002777 acetyl group Chemical group [H]C([H])([H])C(*)=O 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- 239000000853 adhesive Substances 0.000 description 1
- 239000002671 adjuvant Substances 0.000 description 1
- 230000001476 alcoholic effect Effects 0.000 description 1
- 150000001338 aliphatic hydrocarbons Chemical class 0.000 description 1
- 229910052783 alkali metal Inorganic materials 0.000 description 1
- 229910000288 alkali metal carbonate Inorganic materials 0.000 description 1
- 150000008041 alkali metal carbonates Chemical class 0.000 description 1
- 150000008044 alkali metal hydroxides Chemical class 0.000 description 1
- 150000001340 alkali metals Chemical class 0.000 description 1
- 150000001342 alkaline earth metals Chemical class 0.000 description 1
- 239000004411 aluminium Substances 0.000 description 1
- 229910052782 aluminium Inorganic materials 0.000 description 1
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 1
- 235000012211 aluminium silicate Nutrition 0.000 description 1
- 229910021529 ammonia Inorganic materials 0.000 description 1
- 229940035676 analgesics Drugs 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 239000000730 antalgic agent Substances 0.000 description 1
- 230000003501 anti-edematous effect Effects 0.000 description 1
- 239000002260 anti-inflammatory agent Substances 0.000 description 1
- 230000001741 anti-phlogistic effect Effects 0.000 description 1
- 229940111121 antirheumatic drug quinolines Drugs 0.000 description 1
- 150000001492 aromatic hydrocarbon derivatives Chemical class 0.000 description 1
- 150000004945 aromatic hydrocarbons Chemical class 0.000 description 1
- RQPZNWPYLFFXCP-UHFFFAOYSA-L barium dihydroxide Chemical compound [OH-].[OH-].[Ba+2] RQPZNWPYLFFXCP-UHFFFAOYSA-L 0.000 description 1
- 229910001863 barium hydroxide Inorganic materials 0.000 description 1
- 235000013405 beer Nutrition 0.000 description 1
- MSWZFWKMSRAUBD-UHFFFAOYSA-N beta-D-galactosamine Natural products NC1C(O)OC(CO)C(O)C1O MSWZFWKMSRAUBD-UHFFFAOYSA-N 0.000 description 1
- HQABUPZFAYXKJW-UHFFFAOYSA-N butan-1-amine Chemical compound CCCCN HQABUPZFAYXKJW-UHFFFAOYSA-N 0.000 description 1
- 125000004106 butoxy group Chemical group [*]OC([H])([H])C([H])([H])C(C([H])([H])[H])([H])[H] 0.000 description 1
- CQMCIXZEONCDDH-UHFFFAOYSA-N butyl 3-amino-1h-indazole-5-carboxylate Chemical compound CCCCOC(=O)C1=CC=C2NN=C(N)C2=C1 CQMCIXZEONCDDH-UHFFFAOYSA-N 0.000 description 1
- RQNAAYVCNACOAK-UHFFFAOYSA-N butyl 3-amino-5-(trifluoromethyl)indazole-2-carboxylate Chemical compound C1=CC(C(F)(F)F)=CC2=C(N)N(C(=O)OCCCC)N=C21 RQNAAYVCNACOAK-UHFFFAOYSA-N 0.000 description 1
- WVVLSJGNUOOUIF-UHFFFAOYSA-N butyl 3-amino-6-chloroindazole-1-carboxylate Chemical compound C1=C(Cl)C=C2N(C(=O)OCCCC)N=C(N)C2=C1 WVVLSJGNUOOUIF-UHFFFAOYSA-N 0.000 description 1
- KLUCXABFZDTBSK-UHFFFAOYSA-N butyl 6-chloro-3-(dimethylamino)indazole-1-carboxylate Chemical compound C1=C(Cl)C=C2N(C(=O)OCCCC)N=C(N(C)C)C2=C1 KLUCXABFZDTBSK-UHFFFAOYSA-N 0.000 description 1
- NRDQFWXVTPZZAZ-UHFFFAOYSA-N butyl carbonochloridate Chemical compound CCCCOC(Cl)=O NRDQFWXVTPZZAZ-UHFFFAOYSA-N 0.000 description 1
- 125000004063 butyryl group Chemical group O=C([*])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 239000006227 byproduct Substances 0.000 description 1
- 229910000019 calcium carbonate Inorganic materials 0.000 description 1
- AXCZMVOFGPJBDE-UHFFFAOYSA-L calcium dihydroxide Chemical compound [OH-].[OH-].[Ca+2] AXCZMVOFGPJBDE-UHFFFAOYSA-L 0.000 description 1
- 239000000920 calcium hydroxide Substances 0.000 description 1
- 229910001861 calcium hydroxide Inorganic materials 0.000 description 1
- 239000001506 calcium phosphate Substances 0.000 description 1
- 159000000007 calcium salts Chemical class 0.000 description 1
- CJZGTCYPCWQAJB-UHFFFAOYSA-L calcium stearate Chemical compound [Ca+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O CJZGTCYPCWQAJB-UHFFFAOYSA-L 0.000 description 1
- 239000008116 calcium stearate Substances 0.000 description 1
- 235000013539 calcium stearate Nutrition 0.000 description 1
- 125000001589 carboacyl group Chemical group 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 235000014633 carbohydrates Nutrition 0.000 description 1
- 150000001733 carboxylic acid esters Chemical class 0.000 description 1
- 239000000969 carrier Substances 0.000 description 1
- 239000003054 catalyst Substances 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 238000005660 chlorination reaction Methods 0.000 description 1
- AOGYCOYQMAVAFD-UHFFFAOYSA-N chlorocarbonic acid Chemical class OC(Cl)=O AOGYCOYQMAVAFD-UHFFFAOYSA-N 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 239000008119 colloidal silica Substances 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 230000008602 contraction Effects 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 239000003405 delayed action preparation Substances 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 238000006193 diazotization reaction Methods 0.000 description 1
- NEFBYIFKOOEVPA-UHFFFAOYSA-K dicalcium phosphate Chemical compound [Ca+2].[Ca+2].[O-]P([O-])([O-])=O NEFBYIFKOOEVPA-UHFFFAOYSA-K 0.000 description 1
- 229940038472 dicalcium phosphate Drugs 0.000 description 1
- 229910000390 dicalcium phosphate Inorganic materials 0.000 description 1
- 150000004816 dichlorobenzenes Chemical class 0.000 description 1
- ZBCBWPMODOFKDW-UHFFFAOYSA-N diethanolamine Chemical compound OCCNCCO ZBCBWPMODOFKDW-UHFFFAOYSA-N 0.000 description 1
- HPNMFZURTQLUMO-UHFFFAOYSA-N diethylamine Chemical compound CCNCC HPNMFZURTQLUMO-UHFFFAOYSA-N 0.000 description 1
- 229940019778 diethylene glycol diethyl ether Drugs 0.000 description 1
- SBZXBUIDTXKZTM-UHFFFAOYSA-N diglyme Chemical compound COCCOCCOC SBZXBUIDTXKZTM-UHFFFAOYSA-N 0.000 description 1
- DWLVWMUCHSLGSU-UHFFFAOYSA-N dimethylcarbamic acid Chemical compound CN(C)C(O)=O DWLVWMUCHSLGSU-UHFFFAOYSA-N 0.000 description 1
- WEHWNAOGRSTTBQ-UHFFFAOYSA-N dipropylamine Chemical compound CCCNCCC WEHWNAOGRSTTBQ-UHFFFAOYSA-N 0.000 description 1
- 239000007884 disintegrant Substances 0.000 description 1
- 239000002270 dispersing agent Substances 0.000 description 1
- 238000004821 distillation Methods 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 239000000975 dye Substances 0.000 description 1
- 230000002497 edematous effect Effects 0.000 description 1
- OHWOGNSDTPVRRN-UHFFFAOYSA-N ethyl 3-(fluoromethyl)indazole-1-carboxylate Chemical compound C(C)OC(=O)N1N=C(C2=CC=CC=C12)CF OHWOGNSDTPVRRN-UHFFFAOYSA-N 0.000 description 1
- FYZZVYADIHXLGS-UHFFFAOYSA-N ethyl 3-amino-1h-indazole-5-carboxylate Chemical compound CCOC(=O)C1=CC=C2NN=C(N)C2=C1 FYZZVYADIHXLGS-UHFFFAOYSA-N 0.000 description 1
- HOIKMMFFUOGLBQ-UHFFFAOYSA-N ethyl 3-amino-4-chloroindazole-2-carboxylate Chemical compound C1=CC=C(Cl)C2=C(N)N(C(=O)OCC)N=C21 HOIKMMFFUOGLBQ-UHFFFAOYSA-N 0.000 description 1
- DBVCTOUVKNYGTP-UHFFFAOYSA-N ethyl 3-amino-5,7-bis(ethoxycarbonylamino)indazole-1-carboxylate Chemical compound CCOC(=O)NC1=CC(NC(=O)OCC)=C2N(C(=O)OCC)N=C(N)C2=C1 DBVCTOUVKNYGTP-UHFFFAOYSA-N 0.000 description 1
- CJWYYSCUNNIAKO-UHFFFAOYSA-N ethyl 3-amino-5-cyanoindazole-1-carboxylate Chemical compound N#CC1=CC=C2N(C(=O)OCC)N=C(N)C2=C1 CJWYYSCUNNIAKO-UHFFFAOYSA-N 0.000 description 1
- 230000002349 favourable effect Effects 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 125000001153 fluoro group Chemical group F* 0.000 description 1
- 239000008098 formaldehyde solution Substances 0.000 description 1
- 235000019253 formic acid Nutrition 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 230000022244 formylation Effects 0.000 description 1
- 238000006170 formylation reaction Methods 0.000 description 1
- 229920000159 gelatin Polymers 0.000 description 1
- 239000008273 gelatin Substances 0.000 description 1
- 235000019322 gelatine Nutrition 0.000 description 1
- 235000011852 gelatine desserts Nutrition 0.000 description 1
- 229960002442 glucosamine Drugs 0.000 description 1
- 125000004051 hexyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 125000003707 hexyloxy group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])O* 0.000 description 1
- 210000000548 hind-foot Anatomy 0.000 description 1
- 229930195733 hydrocarbon Natural products 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- 125000002346 iodo group Chemical group I* 0.000 description 1
- 159000000014 iron salts Chemical class 0.000 description 1
- 125000000959 isobutyl group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])* 0.000 description 1
- 150000002513 isocyanates Chemical class 0.000 description 1
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 1
- JJWLVOIRVHMVIS-UHFFFAOYSA-N isopropylamine Chemical compound CC(C)N JJWLVOIRVHMVIS-UHFFFAOYSA-N 0.000 description 1
- 150000002537 isoquinolines Chemical class 0.000 description 1
- NLYAJNPCOHFWQQ-UHFFFAOYSA-N kaolin Chemical compound O.O.O=[Al]O[Si](=O)O[Si](=O)O[Al]=O NLYAJNPCOHFWQQ-UHFFFAOYSA-N 0.000 description 1
- 150000002576 ketones Chemical class 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 235000019359 magnesium stearate Nutrition 0.000 description 1
- MYWUZJCMWCOHBA-VIFPVBQESA-N methamphetamine Chemical compound CN[C@@H](C)CC1=CC=CC=C1 MYWUZJCMWCOHBA-VIFPVBQESA-N 0.000 description 1
- UZKWTJUDCOPSNM-UHFFFAOYSA-N methoxybenzene Substances CCCCOC=C UZKWTJUDCOPSNM-UHFFFAOYSA-N 0.000 description 1
- OJURWUUOVGOHJZ-UHFFFAOYSA-N methyl 2-[(2-acetyloxyphenyl)methyl-[2-[(2-acetyloxyphenyl)methyl-(2-methoxy-2-oxoethyl)amino]ethyl]amino]acetate Chemical compound C=1C=CC=C(OC(C)=O)C=1CN(CC(=O)OC)CCN(CC(=O)OC)CC1=CC=CC=C1OC(C)=O OJURWUUOVGOHJZ-UHFFFAOYSA-N 0.000 description 1
- URMZNKZRXMLCQA-UHFFFAOYSA-N methyl 3-amino-4-(trifluoromethyl)indazole-1-carboxylate Chemical compound C1=CC=C2N(C(=O)OC)N=C(N)C2=C1C(F)(F)F URMZNKZRXMLCQA-UHFFFAOYSA-N 0.000 description 1
- MCEBXXSZFFMJLM-UHFFFAOYSA-N methyl 3-amino-4-bromo-2-nitrobenzoate Chemical compound COC(=O)C1=CC=C(Br)C(N)=C1[N+]([O-])=O MCEBXXSZFFMJLM-UHFFFAOYSA-N 0.000 description 1
- RZMWEVDBIGRMGZ-UHFFFAOYSA-N methyl 3-amino-4-chloroindazole-1-carboxylate Chemical compound C1=CC=C2N(C(=O)OC)N=C(N)C2=C1Cl RZMWEVDBIGRMGZ-UHFFFAOYSA-N 0.000 description 1
- GUSXMGLDONQZKF-UHFFFAOYSA-N methyl 3-amino-5-cyanoindazole-2-carboxylate Chemical compound C1=CC(C#N)=CC2=C(N)N(C(=O)OC)N=C21 GUSXMGLDONQZKF-UHFFFAOYSA-N 0.000 description 1
- PVKQIUATGHWTPS-UHFFFAOYSA-N methyl 3-aminoindazole-1-carboxylate Chemical compound C1=CC=C2N(C(=O)OC)N=C(N)C2=C1 PVKQIUATGHWTPS-UHFFFAOYSA-N 0.000 description 1
- 230000011987 methylation Effects 0.000 description 1
- 238000007069 methylation reaction Methods 0.000 description 1
- 239000002480 mineral oil Substances 0.000 description 1
- 235000010446 mineral oil Nutrition 0.000 description 1
- RSAFAYLZKCYUQW-UHFFFAOYSA-N n,n-di(propan-2-yl)carbamoyl chloride Chemical compound CC(C)N(C(C)C)C(Cl)=O RSAFAYLZKCYUQW-UHFFFAOYSA-N 0.000 description 1
- QWULLYSVWIHTKS-UHFFFAOYSA-N n,n-dibutylcarbamoyl bromide Chemical compound CCCCN(C(Br)=O)CCCC QWULLYSVWIHTKS-UHFFFAOYSA-N 0.000 description 1
- OFCCYDUUBNUJIB-UHFFFAOYSA-N n,n-diethylcarbamoyl chloride Chemical compound CCN(CC)C(Cl)=O OFCCYDUUBNUJIB-UHFFFAOYSA-N 0.000 description 1
- HYNKVGHPJRHDMR-UHFFFAOYSA-N n,n-dimethyl-1h-indazol-3-amine Chemical compound C1=CC=C2C(N(C)C)=NNC2=C1 HYNKVGHPJRHDMR-UHFFFAOYSA-N 0.000 description 1
- WIWOGKHWCFGIJI-UHFFFAOYSA-N n,n-dimethyl-5-(trifluoromethyl)-1h-indazol-3-amine Chemical compound C1=C(C(F)(F)F)C=C2C(N(C)C)=NNC2=C1 WIWOGKHWCFGIJI-UHFFFAOYSA-N 0.000 description 1
- DUOKHXDKMZIAGU-UHFFFAOYSA-N n,n-dimethylcarbamoyl bromide Chemical compound CN(C)C(Br)=O DUOKHXDKMZIAGU-UHFFFAOYSA-N 0.000 description 1
- OWPZTVIPDASKEH-UHFFFAOYSA-N n-(3-amino-1h-indazol-5-yl)acetamide Chemical compound CC(=O)NC1=CC=C2NN=C(N)C2=C1 OWPZTVIPDASKEH-UHFFFAOYSA-N 0.000 description 1
- ODNUDOVOVFEZFC-UHFFFAOYSA-N n-(3-amino-1h-indazol-5-yl)formamide Chemical compound C1=C(NC=O)C=C2C(N)=NNC2=C1 ODNUDOVOVFEZFC-UHFFFAOYSA-N 0.000 description 1
- XVNPFBZCDIAZJH-UHFFFAOYSA-N n-(3-amino-5-cyano-1h-indazol-7-yl)formamide Chemical compound C1=C(C#N)C=C2C(N)=NNC2=C1NC=O XVNPFBZCDIAZJH-UHFFFAOYSA-N 0.000 description 1
- AEWJVRSPWHVSCC-UHFFFAOYSA-N n-(5-ethyl-1h-indazol-3-yl)formamide Chemical compound CCC1=CC=C2NN=C(NC=O)C2=C1 AEWJVRSPWHVSCC-UHFFFAOYSA-N 0.000 description 1
- VZCVKAIITHUUIJ-UHFFFAOYSA-N n-[5-(trifluoromethyl)-1h-indazol-3-yl]formamide Chemical compound FC(F)(F)C1=CC=C2NN=C(NC=O)C2=C1 VZCVKAIITHUUIJ-UHFFFAOYSA-N 0.000 description 1
- HNHVTXYLRVGMHD-UHFFFAOYSA-N n-butyl isocyanate Chemical compound CCCCN=C=O HNHVTXYLRVGMHD-UHFFFAOYSA-N 0.000 description 1
- VLOKCGJUEZTWDE-UHFFFAOYSA-N n-ethyl-3-formamidoindazole-1-carboxamide Chemical compound C1=CC=C2N(C(=O)NCC)N=C(NC=O)C2=C1 VLOKCGJUEZTWDE-UHFFFAOYSA-N 0.000 description 1
- ZXAFYFAVCBRKEK-UHFFFAOYSA-N n-ethyl-n-methylcarbamoyl bromide Chemical compound CCN(C)C(Br)=O ZXAFYFAVCBRKEK-UHFFFAOYSA-N 0.000 description 1
- XZVYDRLPXWFRIS-UHFFFAOYSA-N n-ethyl-n-methylcarbamoyl chloride Chemical compound CCN(C)C(Cl)=O XZVYDRLPXWFRIS-UHFFFAOYSA-N 0.000 description 1
- SDEZUJWLTFBSMR-UHFFFAOYSA-N n-methyl-1h-indazol-3-amine Chemical compound C1=CC=C2C(NC)=NNC2=C1 SDEZUJWLTFBSMR-UHFFFAOYSA-N 0.000 description 1
- 125000001971 neopentyl group Chemical group [H]C([*])([H])C(C([H])([H])[H])(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 1
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 description 1
- 125000004430 oxygen atom Chemical group O* 0.000 description 1
- 125000001147 pentyl group Chemical group C(CCCC)* 0.000 description 1
- 239000003208 petroleum Substances 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 238000011197 physicochemical method Methods 0.000 description 1
- XAEFZNCEHLXOMS-UHFFFAOYSA-M potassium benzoate Chemical compound [K+].[O-]C(=O)C1=CC=CC=C1 XAEFZNCEHLXOMS-UHFFFAOYSA-M 0.000 description 1
- 229910000027 potassium carbonate Inorganic materials 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 230000002335 preservative effect Effects 0.000 description 1
- 238000003825 pressing Methods 0.000 description 1
- MFDFERRIHVXMIY-UHFFFAOYSA-N procaine Chemical compound CCN(CC)CCOC(=O)C1=CC=C(N)C=C1 MFDFERRIHVXMIY-UHFFFAOYSA-N 0.000 description 1
- 229960004919 procaine Drugs 0.000 description 1
- IVRIRQXJSNCSPQ-UHFFFAOYSA-N propan-2-yl carbonochloridate Chemical compound CC(C)OC(Cl)=O IVRIRQXJSNCSPQ-UHFFFAOYSA-N 0.000 description 1
- FVSKHRXBFJPNKK-UHFFFAOYSA-N propionitrile Chemical compound CCC#N FVSKHRXBFJPNKK-UHFFFAOYSA-N 0.000 description 1
- 125000001501 propionyl group Chemical group O=C([*])C([H])([H])C([H])([H])[H] 0.000 description 1
- QQKDTTWZXHEGAQ-UHFFFAOYSA-N propyl carbonochloridate Chemical compound CCCOC(Cl)=O QQKDTTWZXHEGAQ-UHFFFAOYSA-N 0.000 description 1
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 239000011253 protective coating Substances 0.000 description 1
- 150000003222 pyridines Chemical class 0.000 description 1
- WQGWDDDVZFFDIG-UHFFFAOYSA-N pyrogallol Chemical compound OC1=CC=CC(O)=C1O WQGWDDDVZFFDIG-UHFFFAOYSA-N 0.000 description 1
- 150000003248 quinolines Chemical class 0.000 description 1
- 239000000376 reactant Substances 0.000 description 1
- 239000011541 reaction mixture Substances 0.000 description 1
- 238000001953 recrystallisation Methods 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 238000010992 reflux Methods 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 229920006395 saturated elastomer Polymers 0.000 description 1
- 238000007789 sealing Methods 0.000 description 1
- 125000002914 sec-butyl group Chemical group [H]C([H])([H])C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- ZLGIYFNHBLSMPS-ATJNOEHPSA-N shellac Chemical compound OCCCCCC(O)C(O)CCCCCCCC(O)=O.C1C23[C@H](C(O)=O)CCC2[C@](C)(CO)[C@@H]1C(C(O)=O)=C[C@@H]3O ZLGIYFNHBLSMPS-ATJNOEHPSA-N 0.000 description 1
- 239000004208 shellac Substances 0.000 description 1
- 229940113147 shellac Drugs 0.000 description 1
- 235000013874 shellac Nutrition 0.000 description 1
- 238000009491 slugging Methods 0.000 description 1
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 1
- 235000017557 sodium bicarbonate Nutrition 0.000 description 1
- 229910000029 sodium carbonate Inorganic materials 0.000 description 1
- 159000000000 sodium salts Chemical class 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 239000008117 stearic acid Substances 0.000 description 1
- 239000008174 sterile solution Substances 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 238000007920 subcutaneous administration Methods 0.000 description 1
- 239000003765 sweetening agent Substances 0.000 description 1
- 208000011580 syndromic disease Diseases 0.000 description 1
- 150000003512 tertiary amines Chemical class 0.000 description 1
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- JCMLRUNDSXARRW-UHFFFAOYSA-N trioxouranium Chemical compound O=[U](=O)=O JCMLRUNDSXARRW-UHFFFAOYSA-N 0.000 description 1
- LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 description 1
- 238000000870 ultraviolet spectroscopy Methods 0.000 description 1
- 238000009736 wetting Methods 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/54—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings condensed with carbocyclic rings or ring systems
- C07D231/56—Benzopyrazoles; Hydrogenated benzopyrazoles
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE2458965A DE2458965C3 (de) | 1974-12-13 | 1974-12-13 | 3-Amino-indazol-N-carbonsäure-Derivate, Verfahren zu ihrer Herstellung sowie sie enthaltende Arzneimittel |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CA1059523A true CA1059523A (en) | 1979-07-31 |
Family
ID=5933305
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA240,662A Expired CA1059523A (en) | 1974-12-13 | 1975-11-27 | 3-aminoindazole-1 and 2-carboxylic acid derivatives |
Country Status (27)
| Country | Link |
|---|---|
| US (1) | US4051252A (enExample) |
| JP (1) | JPS5182266A (enExample) |
| AT (1) | AT343653B (enExample) |
| BE (1) | BE836528A (enExample) |
| CA (1) | CA1059523A (enExample) |
| CH (1) | CH622250A5 (enExample) |
| CS (1) | CS189731B2 (enExample) |
| DD (1) | DD125484A5 (enExample) |
| DE (1) | DE2458965C3 (enExample) |
| DK (1) | DK137082C (enExample) |
| ES (1) | ES443429A1 (enExample) |
| FI (1) | FI753493A7 (enExample) |
| FR (1) | FR2293928A1 (enExample) |
| GB (1) | GB1490306A (enExample) |
| HK (1) | HK52580A (enExample) |
| HU (1) | HU173557B (enExample) |
| IE (1) | IE42208B1 (enExample) |
| IL (1) | IL48642A (enExample) |
| KE (1) | KE3078A (enExample) |
| LU (1) | LU73993A1 (enExample) |
| NL (1) | NL7514521A (enExample) |
| NO (1) | NO145382C (enExample) |
| PL (1) | PL99858B1 (enExample) |
| SE (1) | SE419645B (enExample) |
| SU (1) | SU604487A3 (enExample) |
| YU (1) | YU315275A (enExample) |
| ZA (1) | ZA757777B (enExample) |
Families Citing this family (39)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4431657A (en) * | 1982-05-24 | 1984-02-14 | Ayerst, Mckenna & Harrison Inc. | Analgesic compositions consisting of 2H-benzothieno[3,2-c]pyrazol-3-amine derivatives |
| KR20010086657A (ko) * | 2000-03-02 | 2001-09-15 | 성재갑 | 아미노인다졸 유도체 및 이를 함유하는 싸이클린 의존키나아제 저해제 조성물 |
| CN1926132B (zh) * | 2000-09-15 | 2010-12-29 | 沃泰克斯药物股份有限公司 | 可用作蛋白激酶抑制剂的吡唑化合物 |
| US6660731B2 (en) | 2000-09-15 | 2003-12-09 | Vertex Pharmaceuticals Incorporated | Pyrazole compounds useful as protein kinase inhibitors |
| US7473691B2 (en) * | 2000-09-15 | 2009-01-06 | Vertex Pharmaceuticals Incorporated | Pyrazole compounds useful as protein kinase inhibitors |
| EP1698627A1 (en) * | 2000-09-15 | 2006-09-06 | Vertex Pharmaceuticals Incorporated | Pyrazole compounds useful as protein kinase inhibitors |
| DK1318997T3 (da) * | 2000-09-15 | 2006-09-25 | Vertex Pharma | Pyrazolforbindelser der er nyttige som proteinkinase-inhibitorer |
| HUP0400639A3 (en) | 2000-12-21 | 2010-03-29 | Vertex Pharma | Pyrazole compounds useful as protein kinase inhibitors and pharmaceutical compositions containing them |
| KR100406634B1 (ko) * | 2001-03-12 | 2003-11-20 | 주식회사 엘지생명과학 | 3,5-디아미노인다졸 유도체, 그의 제조방법 및 사이클린의존성 키나아제 저해제로서의 그의 용도 |
| ES2357502T3 (es) | 2001-09-26 | 2011-04-27 | Pfizer Italia S.R.L. | Derivados de aminoindazol activos como inhibidores de quinasa, procedimiento para su preparación y composiciones farmaceuticas que los contienen. |
| KR20040084896A (ko) * | 2002-02-06 | 2004-10-06 | 버텍스 파마슈티칼스 인코포레이티드 | Ｇｓｋ-3의 억제제로서 유용한 헤테로아릴 화합물 |
| FR2836915B1 (fr) * | 2002-03-11 | 2008-01-11 | Aventis Pharma Sa | Derives d'aminoindazoles, procede de preparation et intermediaires de ce procede a titre de medicaments et compositions pharmaceutiques les renfermant |
| ATE468336T1 (de) | 2002-03-15 | 2010-06-15 | Vertex Pharma | Azolylaminoazine als proteinkinasehemmer |
| EP1506176B1 (en) | 2002-05-17 | 2013-04-24 | Pfizer Italia S.r.l. | Aminoindazole derivatives active as kinase inhibitors, process for their preparation and pharmaceutical compositions comprising them |
| MY141867A (en) | 2002-06-20 | 2010-07-16 | Vertex Pharma | Substituted pyrimidines useful as protein kinase inhibitors |
| DE60308387T2 (de) | 2002-08-02 | 2007-09-20 | Vertex Pharmaceuticals Inc., Cambridge | Pyrazolenthaltende zusammensetzungen und ihre verwendung als gsk-3 inhibitoren |
| JP2006512313A (ja) * | 2002-10-31 | 2006-04-13 | アムジェン インコーポレイテッド | 抗炎症剤 |
| WO2004072029A2 (en) | 2003-02-06 | 2004-08-26 | Vertex Pharmaceuticals Incorporated | Pyrazolopyridazines useful as inhibitors of protein kinases |
| JP2007513184A (ja) * | 2003-12-04 | 2007-05-24 | バーテックス ファーマシューティカルズ インコーポレイテッド | プロテインキナーゼのインヒビターとして有用なキノキサリン |
| DE102004005172A1 (de) | 2004-02-02 | 2005-08-18 | Aventis Pharma Deutschland Gmbh | Indazolderivate als Inhibitoren der Hormon Sensitiven Lipase |
| AU2006279376B2 (en) | 2005-08-18 | 2011-04-14 | Vertex Pharmaceuticals Incoporated | Pyrazine kinase inhibitors |
| TW200734327A (en) | 2005-11-03 | 2007-09-16 | Vertex Pharma | Aminopyrimidines useful as kinase inhibitors |
| JP2009533474A (ja) * | 2006-04-14 | 2009-09-17 | アボット・ラボラトリーズ | バニロイドサブタイプ１（ｖｒ１）受容体を阻害するインダゾリルウレアの製造方法 |
| WO2008057940A1 (en) | 2006-11-02 | 2008-05-15 | Vertex Pharmaceuticals Incorporated | Aminopyridines and aminopyrimidines useful as inhibitors of protein kinases |
| WO2008077086A1 (en) | 2006-12-19 | 2008-06-26 | Vertex Pharmaceuticals Incorporated | Aminopyrimidines useful as inhibitors of protein kinases |
| EP2137183B1 (en) | 2007-03-09 | 2011-09-28 | Vertex Pharmaceuticals Incorporated | Aminopyrimidines useful as inhibitors of protein kinases |
| WO2008112642A1 (en) | 2007-03-09 | 2008-09-18 | Vertex Pharmaceuticals Incorporated | Aminopyrimidines useful as inhibitors of protein kinases |
| EP2134709A1 (en) | 2007-03-09 | 2009-12-23 | Vertex Pharmaceuticals, Inc. | Aminopyridines useful as inhibitors of protein kinases |
| JP2010523700A (ja) | 2007-04-13 | 2010-07-15 | バーテックス ファーマシューティカルズ インコーポレイテッド | キナーゼインヒビターとして有用なアミノピリミジン |
| CN101679378A (zh) | 2007-05-02 | 2010-03-24 | 沃泰克斯药物股份有限公司 | 用作激酶抑制剂的噻唑和吡唑 |
| CN101801959A (zh) | 2007-05-02 | 2010-08-11 | 沃泰克斯药物股份有限公司 | 可用作激酶抑制剂的氨基嘧啶类化合物 |
| AU2008247595A1 (en) * | 2007-05-02 | 2008-11-13 | Vertex Pharmaceuticals Incorporated | Aminopyrimidines useful as kinase inhibitors |
| AU2008257044A1 (en) * | 2007-05-24 | 2008-12-04 | Vertex Pharmaceuticals Incorporated | Thiazoles and pyrazoles useful as kinase inhibitors |
| AR067762A1 (es) | 2007-07-31 | 2009-10-21 | Vertex Pharma | Proceso para preparar 5-fluoro-1h-pirazolo (3,4-b) piridin-3-amina y derivados de la misma |
| AU2009288200A1 (en) * | 2008-09-03 | 2010-03-11 | Vertex Pharmaceuticals Incorporated | Co-crystals and pharmaceutical formulations comprising the same |
| DE102009004245A1 (de) | 2009-01-09 | 2010-07-15 | Bayer Schering Pharma Aktiengesellschaft | Neue anellierte, Heteroatom-verbrückte Pyrazol- und Imidazol-Derivate und ihre Verwendung |
| KR102137714B1 (ko) | 2012-07-24 | 2020-07-27 | 바이알 - 포르텔라 앤드 씨에이 에스에이 | 요소 화합물 및 효소 억제제로서 이들의 용도 |
| EP2882712A2 (en) * | 2012-07-27 | 2015-06-17 | BIAL - Portela & Cª S.A. | Process for the synthesis of substituted urea compounds |
| AU2014293731B2 (en) | 2013-07-24 | 2018-03-08 | Bial - Portela & Ca, S.A. | Imidazolecarboxamides and their use as FAAH inhibitors |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3133081A (en) * | 1964-05-12 | J-aminoindazole derivatives | ||
| CH397698A (de) * | 1961-09-08 | 1965-08-31 | Siegfried Ag | Verfahren zur Herstellung neuer 1-Carbamyl-indazole |
| US3277100A (en) * | 1963-05-31 | 1966-10-04 | Du Pont | Novel substituted pyrazoles |
| NL6707299A (enExample) * | 1966-07-16 | 1968-01-17 | ||
| DE1770649A1 (de) * | 1968-06-15 | 1971-11-11 | Bayer Ag | Substituierte 3-Amino-indazole |
-
1974
- 1974-12-13 DE DE2458965A patent/DE2458965C3/de not_active Expired
-
1975
- 1975-10-28 GB GB44299/75A patent/GB1490306A/en not_active Expired
- 1975-11-24 US US05/634,914 patent/US4051252A/en not_active Expired - Lifetime
- 1975-11-27 CA CA240,662A patent/CA1059523A/en not_active Expired
- 1975-11-28 NO NO754024A patent/NO145382C/no unknown
- 1975-12-02 CS CS758165A patent/CS189731B2/cs unknown
- 1975-12-08 SU SU752195302A patent/SU604487A3/ru active
- 1975-12-09 CH CH1599575A patent/CH622250A5/de not_active IP Right Cessation
- 1975-12-10 IL IL48642A patent/IL48642A/xx unknown
- 1975-12-11 LU LU73993A patent/LU73993A1/xx unknown
- 1975-12-11 DD DD190061A patent/DD125484A5/xx unknown
- 1975-12-11 PL PL1975185475A patent/PL99858B1/pl unknown
- 1975-12-11 HU HU75BA3349A patent/HU173557B/hu unknown
- 1975-12-11 BE BE162651A patent/BE836528A/xx unknown
- 1975-12-11 SE SE7513990A patent/SE419645B/xx unknown
- 1975-12-11 AT AT939775A patent/AT343653B/de not_active IP Right Cessation
- 1975-12-11 JP JP50146940A patent/JPS5182266A/ja active Pending
- 1975-12-11 FI FI753493A patent/FI753493A7/fi not_active Application Discontinuation
- 1975-12-12 YU YU03152/75A patent/YU315275A/xx unknown
- 1975-12-12 ZA ZA757777A patent/ZA757777B/xx unknown
- 1975-12-12 NL NL7514521A patent/NL7514521A/xx not_active Application Discontinuation
- 1975-12-12 DK DK567275A patent/DK137082C/da active
- 1975-12-12 IE IE2714/75A patent/IE42208B1/en unknown
- 1975-12-12 FR FR7538124A patent/FR2293928A1/fr active Granted
- 1975-12-12 ES ES443429A patent/ES443429A1/es not_active Expired
-
1980
- 1980-08-29 KE KE3078A patent/KE3078A/xx unknown
- 1980-09-18 HK HK525/80A patent/HK52580A/xx unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CA1059523A (en) | 3-aminoindazole-1 and 2-carboxylic acid derivatives | |
| US3995039A (en) | Pyrazolo [1,5-a] [1,3,5] triazines | |
| IE56836B1 (en) | Novel pharmaceutically active 1,2,3,4,4a,5,10,10a-octahydrobenzo(g)quinoline derivatives | |
| Rousseau et al. | Structure and Ultraviolet Absorption Spectra of Indazole, 3-Substituted Indazole and Some of Their Derivatives1 | |
| CA1120471A (en) | Adamantylmethyl hydrazines, their preparation and pharmaceutical composition containing them | |
| US3162635A (en) | 1, 2, 3, 4-tetrahydro-2, 4-pteridinediones and intermediates | |
| JPS59163353A (ja) | 病気を駆除するためのビスカルボキサミド及びその製法 | |
| US3567765A (en) | N-aromatic substituted acid amides and esters | |
| KR840001131B1 (ko) | 치환된 β-옥소-α-페닐-카바모일-피롤 프로피오니트릴의 제조방법 | |
| GB1568398A (en) | Triazolo pyridazine derivatives | |
| US3775417A (en) | Selective hydrogenation of tri-and tetrazoloisoquinolines | |
| US3984412A (en) | Amino derivatives of pyrido[2,3-b]pyrazine carboxylic acids and esters | |
| US4902698A (en) | Benzenesulphonamidopyridyl compounds which are useful as thromboxane A.sub.2 | |
| US4053621A (en) | 1-[2-(βNaphthyloxy)ethyl]-3-methylpyrazolone-(5) and antithrombotic and antithrombolytic compositions and methods utilizing them | |
| US3935222A (en) | 1,4,5,7-Tetrahydropyrazolo[3,4-b]pyridin-6-ones | |
| US3960959A (en) | N,N'-bis{6-[(3,4-dihydroxyphenyl)alkylamino]-hexyl}hexamethylenediamines and the salts thereof | |
| US2894972A (en) | Isonicotinylhydrazino alkanoic amides | |
| US3956312A (en) | Indazole-3-carboxylic acid hydrazides and a process for the preparation thereof | |
| US4086361A (en) | Aminoethyl oximes having anti-depressive activity | |
| US3957785A (en) | Bβ-Pyrimidino-aminomethyl-10α-ergoline and 10α-methoxyergoline derivatives | |
| NO145238B (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive dihydrokarbostyril-derivater | |
| USRE28939E (en) | 3-Aminoindazole derivatives | |
| US4232160A (en) | Isoquinoline propionamides exhibiting analgesic properties | |
| EP0007648B1 (en) | New acylureas with pharmaceutical activity, the process for their preparation, and pharmaceutical compositions which contain them | |
| US4085102A (en) | 2-Amino-8-arylideno-3,4,5,6,7,8-hexahydro-4-arlypyrido[4,3-d]pyrimidines |